Product Reports Resources Pricing Login Book a demo

Akadeum Life Sciences

Biotech & Life Sciences · Ann Arbor, United States · Founded 2014

Working on the problem of isolating mammalian and bacterial cells from complex mixtures MoreLess

Akadeum Life Sciences, Inc. specializes in advanced cell separation technology using proprietary microbubble technology. This innovative approach allows for rapid and gentle isolation of cells without the need for magnets, making it a valuable tool for researchers in clinical labs and other biotechnical roles. Akadeum's products are designed to improve the quality and reduce the costs of cell separation processes, which are crucial in various life sciences applications, including culture, PCR, and flow cytometry. The company operates in the biotechnology market and serves a diverse range of clients, including research institutions, clinical laboratories, and corporate partners. Akadeum generates revenue through the sale of its cell isolation products and by partnering with other companies to commercialize its microbubble-based technologies. The business model focuses on continuous innovation and collaboration to enhance cell separation workflows and results.

Keywords: microbubble technology, cell isolation, biotechnology, clinical labs, research institutions, flow cytometry, PCR, cell separation, corporate partnerships, innovation.

Company overview

Akadeum Life Sciences company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2014
Headquarters
Ann Arbor, United States
Employees
15
Open positions
None listed
Dealroom signal
62.8
client focusb2bsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorSpinoutsectorBiotech and PharmasectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

Akadeum Life Sciences funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCEquity / VC Aug 2026 $0 Undisclosed
SERIES CEquity / VC Jun 2026 $2.1M $8.5M Undisclosed
LATE VCEquity / VC Jun 2025 $20M $80M Arboretum Ventures · Michigan Capital Network · NYBC Ventures
DEBTDebt Jun 2023 $6.5M Undisclosed
SERIES BEquity / VC May 2023 Michigan Rise
SERIES BEquity / VC Oct 2021 Beringea · Agilent · Michigan Capital Network · Lifespan Investments
SERIES AEquity / VC Dec 2019 Berkeley Catalyst Fund
SEEDEquity / VC Nov 2018 Undisclosed
SPINOUTOther financing Sep 2017 University of Michigan
DEBTDebt Sep 2017 Genoa Ventures
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 14
2025 22
2024 26
2023 30
2022 28
2021 12
2020 12
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Akadeum Life Sciences website traffic

Latest recorded traffic for Akadeum Life Sciences is 36K monthly website visits, up 0% over the last three months. Akadeum Life Sciences's team declined 31.8% over the past year.

Latest monthly visits36K 3-month web change0% 1-year team growth-31.8%
Monthly website visits103 observations · Oct 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Akadeum Life Sciences compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Akadeum Life Sciences's talent

Book a demo to see the people
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

23 investors on Akadeum Life Sciences's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
ELab Ventures
Invest Detroit
Series A 9 investors entered at this stage
Berkeley Catalyst Fund
Arboretum Ventures
Beringea
Agilent
Michigan Capital Network
Lifespan Investments
Michigan Rise
BlueStone Venture Partners
University of Michigan-Dearborn
Series B+ 2 investors entered at this stage
Genoa Ventures
NYBC Ventures
Other known 10 additional known investors
University of Michigan
Hemisphere Ventures
ID Ventures
Invest Michigan
Michigan Biomedical Venture Fund
Michigan State University Research Foundation
Northern Michigan Angels
Red Cedar Ventures
VisionTech Partners
Western Technology Investment

Global footprint

Where Akadeum Life Sciences has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Akadeum Life Sciences

Recent press, funding announcements, and product moves mentioning Akadeum Life Sciences — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Akadeum Life Sciences

An AI-synthesized read of the highest-engagement posts about Akadeum Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Akadeum Life Sciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.